← Back to Search

Unknown

PF-06826647 300 mg QD for Colitis

Phase 2
Waitlist Available
Research Sponsored by Pfizer
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at week 8 and 60

Summary

The purpose of this study is to evaluate efficacy and safety of PF-06826647 in moderate to severe ulcerative colitis

Eligible Conditions
  • Colitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at week 8 and 60
This trial's timeline: 3 weeks for screening, Varies for treatment, and at week 8 and 60 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Participants With Categorical changes from baseline in Vital Signs Data
Percentage of participants achieving endoscopic response
Secondary study objectives
Number of Participants With Categorical Vital Signs Data
Number of Participants With Clinical Laboratory Abnormalities
Percentage of participants achieving clinical remission
+4 more

Trial Design

5Treatment groups
Experimental Treatment
Placebo Group
Group I: PF-06826647 600 mg QDExperimental Treatment1 Intervention
PF-06826647 600 mg QD
Group II: PF-06826647 300 mg QDExperimental Treatment1 Intervention
PF-06826647 300 mg QD
Group III: PF-06826647 100 mg once a day (QD)Experimental Treatment1 Intervention
PF-06826647 100 mg once a day (QD)
Group IV: Open Label Extension, PF-06826647 400 mg QDExperimental Treatment1 Intervention
PF-06826647 400 mg QD
Group V: PlaceboPlacebo Group1 Intervention
Placebo

Find a Location

Who is running the clinical trial?

PfizerLead Sponsor
4,661 Previous Clinical Trials
17,844,989 Total Patients Enrolled
40 Trials studying Colitis
10,431 Patients Enrolled for Colitis
Pfizer CT.gov Call CenterStudy DirectorPfizer
3,546 Previous Clinical Trials
14,886,145 Total Patients Enrolled
32 Trials studying Colitis
9,882 Patients Enrolled for Colitis
~0 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top